ARCHIVES

ORI Misconduct Findings Announced In Two Cases

This article is from The Cancer Letter archive.

Vol. 22 No. 28 | July 12, 1996

Download PDF Visit The Full Archive

Related Articles

Solomon Gard Loses Final Cancer Battle

February 12, 1982

BMS Control Of Billion-Dollar Taxol Market Facing Court Challeges By Competitors

May 29, 1998

Final Issue of the Year

December 13, 1985

Economic Analysis Finds Erlotinib Marginally Cost-Effective For NSCLC

February 26, 2010

In Brief: Jane Henney Sworn In As FDA Commissioner; Six Centers Retain Comprehensive Status

December 18, 1998

Judge Declines To Issue Injunction To Stop Amgen’s “Bundling.”

December 1, 2006